Posts by Wavemind
Kick-off Medtech Accelerator at EPFL Innovation Park
Monday 12 March @ 17:30, at room Neptune, Building C of EPFL Innovation Park Learn more about La Forge’s new expert coaching programs for a selection of verticals. The first vertical acceleration track will be dedicated for Medtech related projects! Don’t miss your chance and sign up to the event here. Programme information
Read MoreCompugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of An
Selexis SA announces that Compugen Ltd. has taken a license to the Selexis SUREtechnology Platform™ for use in generating high-performance research cell banks (RCBs). All the information you wish to know about this news is accessible here.
Read MoreSelexis SA and Xencor sign 4 Commercial License Agreements
On 26 February, Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody Drug Candidates Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, today announced that it has signed four commercial license agreements (CLAs) with Xencor, Inc. (NASDAQ: XNCR), a…
Read MoreUNIBE – Des cultures cellulaires en 3D contre les résistances des cancers
La médecine de précision, c’est-à-dire la mise au point de traitements personnalisés, est un objectif majeur de la recherche moderne contre le cancer. Une équipe de chercheurs de l’université de Berne a développé des cultures cellulaires en 3D (dits organoïdes) en collaboration étroite avec le Netherlands Cancer Institute (NKI) d’Amsterdam et l’Hubrecht Institut d’Utrecht afin…
Read MoreBusiness offer from a German company represented by the Enterprise Europe Network
A German company, part of the Enterprise Europe Network, specialized in planning and interior fitting of hospitals and veterinary clinics offers sales representation of its products and services world-wide. A German company, part of an international group, specialized in planning and interior fitting of hospitals, offers sales agents or distributors sales representation of its products…
Read MoreFerring: 30 million CHF investment in new biotech centre in Switzerland
Ferring expands its capabilities in biologics through a new biotech centre, which will be installed at its global headquarters and manufacturing site in Saint-Prex. The Biotech Centre will incorporate discovery and development capabilities for biologics. Saint-Prex, Switzerland – 14 February 2018 Ferring Pharmaceuticals announced today that it is expanding its capabilities in biologics through a…
Read MoreLS2 Annual Meeting 2018
The biggest Life Sciences conference in Switzerland takes place at the University of Lausanne February 12-13, 2018 The LS² Annual Meeting 2018 with the topic “Metabolism & Signaling in the Life Sciences”, will be held on the 12th and 13th of February, 2018 at the Amphimax/Amphipôle Campus of the University of Lausanne. The LS² Annual Meeting brings together…
Read MoreFondation BINC-Geneva – Appels à candidatures
Appels à candidatures pour des financements de recherche (académiques) dans les domaines du microbiote, allergie, obésité infantile et dépression postpartum. Biostime Institute for Nutrition and Care-Geneva invite les chercheurs scientifiques basés dans les universités, hôpitaux et autres institutions académiques à candidater aux programmes de financement de recherche. Les subventions de recherche visent à soutenir des projets…
Read MoreBilan – Les start-up suisses lèvent un milliard en 2017
600 millions de francs d’investissements en 2017 pour les start-ups Medtech et Biotech en Suisse Lire l’article complet sur la page de Bilan
Read MoreQuatre plateformes promeuvent l’innovation en Suisse occidentale
Le Journal Entreprise romande nous dévoile les coulisses des quatres plateformes sectorielles de Suisse occidentale L’article complet est disponible ici.
Read More